Pregnenolone sulfate (PS) is a neuroactive steroid hormone produced in the brain. In this study, the effects of PS on synthesis and secretion of rat pituitary prolactin (PRL) were examined. To accomplish this, GH3 rat pituitary adenoma cells were treated with PS, which showed significantly increased mRNA and protein levels of PRL compared with the control. The mechanism of action responsible for the effects of PS on PRL synthesis and secretion was investigated by pretreating cells with inhibitors of traditional PRLor the PS-related signaling pathway. PS-stimulated PRL transcription was significantly reduced by inhibitors of PKA, PKC and MAPK, but unchanged by GABAAR and NMDAR inhibitors. Western blotting analysis revealed that the total ERK1/2 level was upregulated in a time-dependent manner following PS treatment. An approximate 10% increase in GH3 cell proliferation was also observed in response to PS relative to the control. In the animal study, levels of PRL in the pituitary and in serum were elevated by PS. PS-stimulated PRL synthesis was also found to be associated with decreased expression of PRL target genes such as GNRH1, FSHB and LHB. These findings show that PS upregulates PRL synthesis and secretion in vivo and in vitro via MAPK signaling, suggesting that it has the potential for use as a therapeutic hormone to treat PRLrelated disorders such as hypoprolactinemia and low milk supply.
Introduction
Prolactin (PRL) is a polypeptide hormone synthesized and secreted from specialized cells of the anterior pituitary gland, which is known for its multiple effects on the female mammary gland, including regulation of growth and development of the gland (mammogenesis), synthesis of milk (lactogenesis) and maintenance of milk secretion (galactopoiesis) (Freeman et al. 2000) . In addition, the range of PRL functions has greatly increased in females and males. An early review revealed that PRL had 85 functions (Cowie 1973) , which has subsequently 230:3 been updated to over 300, including immune functions, reproduction, osmoregulation and behavior (Bole-Feysot et al. 1998) .
PRL-inhibiting factors (PIFs) and PRL-releasing factors (PRFs) supplied by neurosecretory cells control synthesis and secretion of PRL from the pituitary (Arey et al. 1989 , Lamberts & Macleod 1990 . The PIF includes dopamine (DA), somatostatin and gamma-aminobutyric acid (GABA), whereas PRF includes thyrotropin-releasing hormone (TRH), neurotensin and oxytocin. Internal milieu such as suckling, stress and increased levels of ovarian steroids modulate PRF and PIF activities, which transduce PRL-regulating signals (Meites et al. 1963 , Neill 1970 , Terkel et al. 1972 .
DA is the predominant hypothalamic factor involved in regulation of PRL synthesis and secretion. In addition, factors influencing the dopaminergic tone in lactotrophs have been investigated to illuminate the complex connection between PRL and DA. DA directly influences lactotrophs by binding to the D2 receptor (D2R) subclass expressed on their cell membranes (Lefkowitz & Labrie 1978) . Other pituitaryderived factors also regulate PRL secretion, including transforming growth factor alpha (TGF-α), transforming growth factor beta (TGF-β), interleukins and galanin (Sarkar et al. 1998) . In addition, the secretion and synthesis of PRL are modulated by calcium (Ca 2+ ) concentration. PRL secretion is sensitive to changes in extracellular Ca 2+ concentration in normal rat pituitary cells in vitro. TRH stimulates PRL release via elevated intracellular free Ca 2+ (Gershengorn 1986 ). Chelation of extracellular Ca 2+ has been shown to reduce PRL secretion and synthesis in the GH3 pituitary cells. TRH-stimulated PRL secretion is also suppressed by reduction of Ca 2+ and verapamil (Ca 2+ channel blocker) (Gershengorn & Thaw 1985) .
Transcription of PRL likely involves activation of protein kinases, which leads to phosphorylation of specific regulators such as PIF and PRF. Activation of cAMP-dependent protein kinase (PKA), protein kinase C (PKC), Ca 2+ /calmodulin-dependent protein kinase type II, or the mitogen-activated protein kinase (MAPK) cascade has been shown to be sufficient to stimulate transcription of the PRL gene. The PRL promoter contains multiple binding sites for tissue-specific transcription factor including pituitary-specific positive transcription factor 1(PIT-1), and PIT-1 binding sites may contribute to hormonally regulation and basal transcription of PRL. The finding that cAMP or phorbol ester treatment of GH3 cells stimulates phosphorylation of PIT-1 is consistent with a role of PIT-1 in regulation of PRL transcription (Kapiloff et al. 1991) .
Pregnenolone sulfate (PS) is an endogenous neuroactive steroid metabolized from pregnenolone (P5), which is a precursor of endogenous steroid hormones such as progesterone (P4) and estrogen (E 2 ). Neuroactive steroids synthesized directly in the brain are independent from peripheral sources and rapidly alter neuronal excitability by binding to their receptors (Baulieu 1998) . PS is endogenously present in the brain and synthesized by glial cells, which has been shown to modulate neurotransmission in a variety of systems via both presynaptic and postsynaptic mechanisms (Bowlby 1993) . PS is also known to have cognitive and memoryenhancing, antidepressant, anxiogenic and proconvulsant effects (Reddy 2010) .
Although PS is defined as a neurosteroid hormone, its mechanisms and functions have not been well established. Neuroactive steroids including PS could affect the pituitary cells (Le Foll 1997) . Therefore, this study examined the effects of PS on synthesis and secretion of PRL and also the PRL target genes in the rat pituitary.
Materials and methods

Cell culture and treatments
GH3 rat pituitary epithelial-like tumor cells were cultured in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS; Welgene, Seoul, Korea), 100 U/mL penicillin, and 100 μg/mL streptomycin (Welgene) at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. Cells were seeded in DMEM culture medium. After 24 h the medium was replaced by phenol red-free DMEM (Sigma-Aldrich) supplemented with 10% charcoal/dextran-treated FBS (Hyclone, Logan, UT, USA), 100 U/mL penicillin and 100 μg/mL streptomycin for 24 h before treatment. All the chemicals for treatment were dissolved in ethanol, diluted with experimental medium, and added to the cell culture medium. The tumor cells were treated with E 2 (100 nM), P4 (10 μM), P5 (10 μM), PS (100 μM) or ethanol (EtOH) to obtain the vehicle control. The cells were also pretreated with muscimol (Mus; 10 μM), 3-[(R)-2-carboxypiperazin-4-yl]-prop-2-enyl-1-phosphonic acid (CPP; 10 μM), H89 (10 μM), staurosporine (Sta; 1 μM) or PD98059 (PD; 10 μM) 1 h before PS treatment to block PRL or PS signaling.
Experimental animals and treatments
Immature female Sprague-Dawley (n = 30) rats were acquired from Samtako (Osan, Republic of Korea). The rats were housed at the Pusan National University Laboratory Animal Resources Center, which is accredited by the Korea FDA, according to the National Institutes of Health guidelines. The rats were housed in cages under a 12 h light:12 h darkness cycle and a constant temperature of 23 ± 1°C. The Ethics Committee of Pusan National University (Busan, Republic of Korea) approved all experimental animal procedures (approval number; PNU-2014-0665). Rats were treated daily with PS (10 mg/kg/day), E 2 (40 μg/kg/day), P4 (1 mg/kg/day), P5 (10 mg/kg/day) or corn oil (vehicle control) via subcutaneous injection (SC) from postnatal days (PNDs) 17 to 19. Dosage was adjusted according to changes in body weight (BW); BW, clinical signs and abnormal behaviors were recorded daily throughout the experimental period. On PND 20, all animals were killed using CO 2 gas, after which tissue and serum samples were collected.
Quantitative real-time PCR
Total RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. RNA was measured using a spectrophotometer. Firststrand complementary DNA (cDNA) was prepared from total RNA (3 μg) by reverse transcription (RT) using M-MLV reverse transcriptase (Invitrogen) and random primers (9-mers; Takara Bio). Quantitative real-time PCR (Q-PCR) was performed using cDNA template (2 μL) and 2× Power SYBR Green (6 μL; TOYOBO Co Ltd, Katata, Ohtsu, Japan) containing specific primers. Primer sequences for PRL, D2R, PIT-1, V-Ets Avian Erythroblastosis Virus E 2 6 Oncogene Homolog 1 (ETS-1), gonadotropin-releasing hormone (GNRH1), gonadotropin-α, follicle-stimulating hormone beta (FSHB), and luteinizing hormone beta (LHB) are shown in Table 1 . Real-time PCR was conducted by subjecting the samples to 40 cycles of denaturation at 95°C for 15 s, followed by annealing and extension at 70°C for 60 s. Fluorescence intensity was measured at the end of the extension phase of each cycle. The threshold value for fluorescence intensity of all samples was set manually. The reaction cycle at which the PCR products exceeded this fluorescence intensity threshold during the exponential phase of PCR amplification was considered to be the threshold cycle (CT). Expression of the target gene was quantified relative to that of β-actin, a ubiquitous housekeeping gene, based on the comparison of CTs at constant fluorescence.
Western blotting analysis
Protein samples of GH3 cells were extracted with cell lysis buffer (20 mM Tris, 100 mM NaCl, 0.5% NP-40, 0.5 mM EDTA, 0.5% protease inhibitor cocktail). A total 30 μg of protein (15 μL of protein in serum, n = 3) were separated by 10-12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to nitrocellulose membranes (Daeillab Service Co, Ltd, Seoul, Korea). Membranes were subsequently blocked for 1 h with 5% skim milk (Difco, Spark, MD, USA) in Tris-buffered saline (TBS) with 0.05% Tween 20 (TBS-T). The blocked membranes were incubated with antibodies specific for PRL, extracellular signal-regulated kinases 
MTT assay
GH3 cells (3 × 10 4 cells/well) were seeded on 96-well plates in 200 μL DMEM containing 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were then allowed to attach to the bottom during 24 h of incubation, after which the seeding medium was removed and replaced with experimental medium (phenol red-free DMEM supplemented with 10% charcoal/dextran-treated FBS, 100 U/mL penicillin and 100 μg/mL streptomycin) for 24 h before treatment. Cells were treated with E 2 (100 nM), P4 (10 μM), PS (100 μM) or EtOH (vehicle control) for 24 h, after which 50 μL 3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyl tetrazolium bromide (MTT) solution (2 mg/mL) was added to 200 μL medium without phenol red, and the plates were incubated for 4 h at 37°C. DMSO was added to all wells and mixed thoroughly to dissolve the dark blue crystals. After a few minutes at room temperature to ensure that all crystals were dissolved, the absorbance in the wells was measured at 570 nm with a reference wavelength of 650 nm.
Cell proliferation assay
5-bromo-2'-deoxyuridine (BrdU) assays were conducted using Cell Proliferation ELISA, BrdU kit (Roche) according to the manufacturer's recommendations. GH3 cells were cultured in the same condition with MTT assay. Cells were treated with E 2 (100 nM), PS (100 μM) or EtOH (vehicle control) for 24 h, after which 10 μL BrdU solution (100 μM) were added to each well in 100 μL phenol redfree medium, and the plates were incubated for 8 h at 37°C. Then the cells were fixed using 200 μL FixDenat (Roche) for each well for 30 min, and incubated with BrdU antibody for 90 min at room temperature. After washing, the cells were incubated with 100 μL substrate for 30 min and then 25 μL 1 M H 2 SO 4 were added. Absorbance was measured at 450 nm.
Statistical analyses
The results are presented as mean ± standard deviation (s.d.). Data were analyzed using one-way analysis of variance (ANOVA) (SPSS for Windows, Release 10.10, Standard Version, Chicago, IL, USA). P values <0.05 were considered statistically significant.
Results
Regulation of PRL expression by PS in GH3 cells
To investigate the effects of PS on pituitary PRL regulation, GH3 cells were treated with PS or its metabolites, including E 2 , P4 and P5 for 24 h. The mRNA and protein levels of PRL were upregulated in response to PS by approximately two-to three-folds, whereas P4 and P5 reduced the PRL mRNA and protein
Figure 1
Regulation of PRL expression by PS in GH3 cells. Transcriptional (A) and translational (B) levels of PRL were evaluated after treatment of GH3 cells with E 2 , P4, P5 and PS. The mRNA expression of PRL after PS treatment was tested in a dose-dependent (C) and time-dependent (D) manner.
(E) Protein production of PRL in growth medium secreted from GH3 cells was analyzed. The mRNA and protein levels were analyzed by Q-PCR and Western blotting assay. Data are expressed as the mean ± s.d. of triplicate experiments. The expression level of PRL was normalized to that of an internal control, β-actin. Protein in growth medium was normalized to total protein stained with Coomassie Brilliant Blue. *P < 0.05 relative to the control group. A full colour version of this figure is available at http://dx.doi.org/JOE-16-0008.
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levels ( Fig. 1A and B) . These results suggest that PS upregulates PRL synthesis, which is different from its precursor (P5) and metabolites (E 2 and P4). Treatment with increasing concentrations (10 −7 , 10 −6 , 10 −5 , 10 −4 and 2 × 10 −4 M) of PS for 24 h resulted in significantly elevated PRL mRNA levels at concentrations of 10 −4 and 2 × 10 −4 M in a dose-dependent manner (Fig. 1C) . In Fig. 1D , the basal expression of PRL mRNA was gradually decreased according to the duration of culture, which may be due to autocrine regulation of PRL itself. The mRNA expression was upregulated from 8 to 48 h when the cells were treated with PS, with the maximum effect occurring at 24 h compared with control (Fig. 1D) .
To confirm the regulation of PRL by PS, we further examined the amount of PRL in a medium of GH3 cells after PS treatment (Fig. 1E) . The amount of PRL in the cell culture media was enhanced as the cell culture time goes as we expected. Similar to mRNA levels, the amount of PRL in the media was increased by PS compared with control.
Mechanisms of PRL regulation by PS in GH3 cells
GH3 cells were pretreated with the type-A GABA receptor (GABA A R) activator, Mus, or the N-methyl-d-aspartate receptor (NMDAR) inhibitor, CPP, for 1 h before PS administration to examine how PS regulates PRL levels. Neither Mus nor CPP significantly altered PRL mRNA levels ( Fig. 2A and B) . These results suggest that PRL transcription stimulated by PS in GH3 cells is not mediated by GABA A R-or NMDAR-related signaling pathways. To further explore PS signaling, we pretreated GH3 cells with PKA inhibitor (H89), PKC inhibitor (Sta) or MAPK inhibitor (PD) for 1 h before PS. Enhanced transcription of PRL in response to PS was significantly inhibited by H89, Sta and PD compared with PS alone (Fig. 2C, D and E). Total ERK1/2 or phosphorylated forms of ERK1/2 and p38 were examined by Western blotting. The total ERK1/2 level was elevated in a time-dependent manner, peaking at 10-30 min after PS treatment (Fig. 3A) . However, no significant change in p-ERK1/2, p38 and p-p38 levels were observed. Evaluation of other After treatment of GH3 cells with PS, protein levels of p-ERK1/2, ERK1/2, p-p38 and p38 were analyzed by Western blotting assay. The mRNA levels of PIT-1 (B), ETS-1 (C) and D2R (D) were analyzed by Q-PCR. Cell proliferation was analyzed by MTT (E) and BrdU (F) assays after treatment of GH3 cells with E 2 and PS. Data are expressed as mean ± s.d. The mRNA and protein expression levels were normalized to that of an internal control, β-actin. *P < 0.05 compared with the control group.
230:3
well-known transcriptional regulators of PRL, including PIT-1, ETS-1 and D2R, was tested, which revealed that their expression levels were not significantly altered by PS (Fig. 3B, C and D) .
Effect of PS on GH3 cell proliferation
To determine if PS modulates the proliferation of GH3 cells, we conducted MTT and BrdU assays. GH3 cells were treated with PS for 24 h, after which the rate of proliferation was measured. Cell proliferation was elevated by approximately 10% in response to PS relative to the control in both MTT and BrdU results ( Fig. 3E and  F) , suggesting that not only PRL production but also proliferation of PRL-secreting cells are augmented by PS.
Regulation of PRL expression and secretion by PS in immature rats
Following the in vitro results showing the elevation of PRL by PS in GH3 cells, we next examined the effects of PS in vivo using immature female rats. As it is known that PRL is regulated by sex steroid hormones such as E 2 and P4, we performed the experiment in sexually immature rats. The rats were treated with PS or corn oil as a vehicle control from PNDs 17 to 19, and then killed on PND 20. For comparison, P4, an endocrine metabolite of P5, was also administered. Expression of PRL in the pituitary of immature female rats was tested first because the pituitary is the main organ that produces PRL. Consistent with the results of GH3 cells, transcription of PRL increased by approximately two-fold in response to PS (Fig. 4A) . To measure the amount of PRL secreted from the pituitary, PRL levels in serum were analyzed by Western blotting. PRL protein levels were upregulated by PS in serum, similar to that in the pituitary (Fig. 4B) . However, E 2 and P4 showed Figure 4 Regulation of PRL expression and secretion by PS in immature rats. Immature female rats were administrated E 2 , P4 and PS for 3 days, after which pituitary mRNA (A) and serum protein (n = 3) (B) levels of PRL were analyzed by Q-PCR and Western blotting assay. Data are expressed as mean ± s.d. The mRNA and protein expression levels were normalized to that of total protein. *P < 0.05 compared with the control group. A full colour version of this figure is available at http://dx.doi.org/JOE-16-0008. 
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no significant change in serum. Then, the expression of PRL target genes such as GNRH1, gonadotropin-α, FSHB and LHB in the pituitary was then evaluated. Among the target genes, mRNA expression of GNRH1, FSHB and LHB was reduced significantly, whereas gonadotropin-α expression was unchanged (Fig. 5 ).
Discussion
Secretion of pituitary PRL is regulated by DA, and gonadal and pituitary hormones (Fitzgerald & Dinan 2008) . E 2 regulates PRL gene expression within the anterior pituitary gland by binding to its nuclear receptor and then conferring DNA binding and transcriptional activation of the gene. The ability of physiological E 2 to elicit cellular Ca 2+ influx via a membrane version of ERα was demonstrated previously (Wozniak et al. 2005) . P4 is a neurosteroid that decreases PRL synthesis and secretion, leading to inhibition of E 2 -induced PRL gene expression. P5, a precursor of steroid hormones, downregulates PRL via conversion to P4 by 3beta-hydroxysteroid dehydrogenase (3β-HSD) (Assairi et al. 1974) .
In this study, we examined the effects of PS on pituitary PRL regulation in vivo and in vitro. GH3 rat pituitaryderived cells that synthesize and secrete PRL were treated with E 2 , P4, P5 and PS. PS significantly increased PRL mRNA and protein levels, whereas P4 and P5 reduced PRL levels. PRL levels were elevated in growth medium by PS in a time-dependent manner compared with the negative control. These results indicate that PS upregulates both PRL synthesis and secretion. Although it has been known that E 2 upregulates PRL production in GH3 cells, it did not significantly change in our experimental condition.
Because PRL secretion and synthesis increased in response to PS, we examined the mechanism of action of PS. To accomplish this, GH3 cells were pretreated with signaling inhibitors of PS action in the brain. PS is an excitatory neurosteroid in the brain that acts as a potent negative allosteric modulator of GABA A R and a weak positive allosteric modulator of NMDAR (Majewska et al. 1988 , Wu et al. 1991 . GABA A R is an ionotropic receptor and a ligand-gated ion channel that increases the membrane conductance for Cl − ions upon activation, leading to hyperpolarization and reduced excitability of neurons (Majewska et al. 1988) . NMDAR is an ion channel protein that enables the flow of positively charged ions through the cell membrane when activated (Irwin et al. 1992) . Transcription of PRL induced by PS was unchanged following pretreatment with GABA A R and NMDAR inhibitors, indicating that PS may have different signaling pathways for the PRL regulation than its known signaling pathways. Activation of protein kinases, including PKA, PKC or MAPK, leads to phosphorylation of specific PRL regulating factors such as PIT-1 and ETS-1. Therefore, we tested PRL expression in the absence and presence of PKA, PKC and MAPK inhibitors. The results showed that PS regulated PRL gene expression via the activation of protein kinases. In addition, total ERK1/2 levels were elevated in a time-dependent manner after PS treatment, whereas the levels of phosphorylated ERK1/2 did not change. Although ERK1/2 proteins are mainly regulated by phosphorylation, evidence shows that posttranslational modifications of ERK1/2 other than phosphorylation could be involved in cellular response (Luanpitpong et al. 2012) . Taken together, these findings indicate that activities of these factors may be linked via PKA, PKC and MAPK.
Although E 2 and P4 regulated the mRNA expression of PRL in the pituitary, they did not affect PRL levels in the serum. The distinct results between mRNA and serum PRL levels may be due to the presence of other regulatory systems rather than the pituitary. Regarding the effects of PS, the results of in vivo study were similar to those of in vitro study. Transcription levels of PRL in the pituitary were elevated by approximately two-fold in response to PS. The amount of PRL was also analyzed by Western blotting assay in rat serum, which showed that PRL was upregulated by PS. However, these results demonstrate that both secretion and synthesis of PRL were increased in response to PS in immature rats. Elevated PRL may affect reproduction through its action on the GnRH neurons of the hypothalamus and/or on the pituitary gland, and secretion of the gonadotropins, LH and FSH (Grattan et al. 2007) . Increased PRL expression tends to suppress expression and secretion of GnRH through PRL receptors from the hypothalamus, which reduces FSH and LH secretion from the anterior pituitary. Therefore, abnormal PRL concentration such as hyperprolactinemia and hypoprolactinemia can cause infertility in woman through interference of ovarian function (Kauppila et al. 1988) . LH and FSH are heterodimers composed of α-and β-subunits, which are associated noncovalently (Kooy et al. 1990) . In this study, the elevated PRL after PS treatment reduced the expression of GNRH1, FSHB and LHB. However, gonadotropin-α levels were not significantly altered. Many studies have shown that gonadotropin-α is differentially regulated from β-subunits, and that regulation of β-subunits is sufficient to modulate FSH and LH production (Kaiser et al. 1997) .
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Taken together, these findings indicate that PS triggered activation of PKA and PKC, followed by MAPK signaling, enhanced PRL synthesis and secretion, and enhanced the proliferation of GH3 cells. The effects of PS were further evidenced in vivo based on the increased expression of PRL and the downregulation of PRL target genes. These results suggest that PS is a potential steroid hormone that can be applied to patients with PRL-related disorders such as hypoprolactinemia and milk supply.
